Tag: oncology

Paige.AI Lands $25 Million Series A Financing and 25 Million Slides from Memorial Sloan Kettering

| February 8, 2018 | 0 Comments

25 million slides in an exclusive relationship with MSK and 25 million dollars in funding are some big numbers.  Paige.AI, a new company focused on revolutionizing clinical diagnosis and treatment in oncology through use of artificial intelligence (AI), recently announced two major milestones: Paige.AI signed a comprehensive license agreement with Memorial Sloan Kettering Cancer Center (MSK) to gain […]

Continue Reading

TRIBVN Healthcare Announces Launch of the New Version of CaloPix

| September 14, 2017 | 0 Comments

TRIBVN Healthcare, a publisher of software solutions for diagnostic cellular and tissue imaging in the laboratory, announces the launch of the latest version of the CaloPix 3.2.0 software, which is dedicated to the management and analysis of images for diagnostic and clinical applications. Version 3.2.0 of CaloPix is available. This is a major version, which represents […]

Continue Reading

Inspirata Marks 1st Anniversary of 10-Year Engagement at Ohio State’s James Cancer Hospital and Solove Research Institute with Behind-the-Scenes Look at the Groundbreaking Digital Pathology Project

| July 26, 2017 | 0 Comments

Inspirata will be offering a behind-the-scenes look at its work with the cancer hospital during a Corporate Workshop it is hosting on Thursday, July 27th from 3:00 – 4:30 at the Association of Pathology Chairs (APC) Annual Meeting this week in Washington, DC. Washington, DC, July 26, 2017 – Cancer diagnostics and pathology workflow solution provider […]

Continue Reading

Inspirata, a Silver Sponsor and Exhibitor at USCAP 2017 in San Antonio, to Demonstrate its New Digital Pathology Consultation Portal and Cockpit Features

| March 3, 2017 | 0 Comments

Stop by booth #310 to learn about Inspirata’s Cancer Diagnostics Workflow Solution, Precision Medicine Platform and International Consultation Portal. Tampa, FL, March 3, 2017/PRWeb – Cancer diagnostics workflow solution provider Inspirata, Inc. is a Silver sponsor and exhibitor at the upcoming USCAP 2017 in San Antonio March 6-8. As part of the expo, Inspirata will […]

Continue Reading

‘Crosswalk’ Re-Launched to Make it Easier to Bridge the Gap Between Pathology, Precision Diagnosis and Precision Medicine

| February 20, 2017 | 1 Comment

Inspirata has just released new mobile and Web-based versions of “Crosswalk Insight: Oncology™,” a knowledge visualization platform that enables users to easily navigate through tumor images and the associated molecular pathways, targeted therapies and clinical trials. San Francisco, CA, February 20, 2017 – Cancer diagnostics and pathology workflow solution provider Inspirata®, Inc. announced today the re-launch […]

Continue Reading

Inspirata Acquires Precision Medicine Network, Inc. and the ‘Crosswalk’ Platform to Bridge the Gap Between Digital Pathology and Molecular Oncology

| September 13, 2016 | 0 Comments

“Crosswalk Insight™: Oncology” enhances Inspirata’s Digital Pathology Cockpit by providing access to Genomic Profiles, FDA-Approved Targeted Therapies, Immunotherapies and Clinical Trials to enable pathologists to make more precise diagnostic and therapeutic decisions. Tampa, FL, September 13, 2016 – Cancer diagnostics and digital pathology workflow solution provider Inspirata, Inc. announced today that it has acquired the assets […]

Continue Reading

“Herceptoid” and “Personalized” Medicine

| September 30, 2015 | 0 Comments

Over the summer a longtime friend asked if I could review some slides for a friend of his, or actually from his friend’s wife. Of course I agreed to do so. He mentioned that she had “metastatic breast cancer” and wanted to make sure the slides fit that diagnosis to insure she was getting the […]

Continue Reading

Definiens Releases Biomarker Datafication Services for Oncology Clinical Development

| June 1, 2015 | 0 Comments

New Offering Announced at ASCO 2015 Provides Valuable Data for Clinical Program Decision Making MUNICH- Definiens, the global leader in image analysis for digital pathology and diagnostics, today announced a new suite of Biomarker Datafication Services for oncology clinical development programs. This package of services enables pharmaceutical and biotech companies to gather comprehensive data from their […]

Continue Reading

Philips and Indica Labs Team to Accelerate Cancer Research through Advanced Image Analysis

| January 15, 2015 | 0 Comments

Best, Netherlands and New Mexico, USA – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it will further support oncology researchers’ efforts to analyze pathology samples by offering advanced image analysis algorithms from Indica Labs, Inc. as part of its Digital Pathology Solutions offerings. The collaboration will allow pathology researchers to apply intelligent algorithms to digitized […]

Continue Reading

Upcoming Webinar from Definiens – Best Practices in IHC-based Tissue Image Analysis for Immuno-oncology, Oncology and Diabetes

| January 11, 2015 | 0 Comments

Presenters: Anindita Bhoumik, M.S., Scientist, R&D, ViaCyte, Inc. Jeff Dzubay, Ph.D., Field Application Scientist, Definiens Douglas Bowman, Associate Scientific Fellow, Takeda Pharmaceuticals International Co. Broadcast #1: Wednesday, January 14, 2015 2pm GMT (UK) / 3pm CET (EU-Central) / 9am EST (NA) Broadcast #2: Wednesday, January 14, 2015 1pm EST (NA) / 10am PST The use […]

Continue Reading

Definiens Releases Tissue Studio® 4.0 for Quantitative Digital Pathology

| December 8, 2014 | 0 Comments

 Continues Leadership in Simplifying Tissue Image Analysis and Improving Workflow Efficiency MUNICH — Definiens, the global leader in Tissue Phenomics® for oncology diagnostics announced the newest version of its leading image analysis software for quantitative digital pathology, Tissue Studio 4.0. The new release provides greater flexibility, more accurate and consistent results, and the ability to use any […]

Continue Reading

Philips Digital Pathology Solution Receives CE Mark for Diagnosis to Help Advance Oncology Diagnosis

| October 17, 2014 | 0 Comments

CE mark includes diagnosis for routine pathology Best, The Netherlands—Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has acquired the CE mark for diagnostic use of its Philips Digital Pathology Solution. European pathologists will now be able to use the full digital solution as an aid in diagnosis for routine pathology, such as primary […]

Continue Reading

Where do Pathologists fit into Accountable Care Organizations? – Part 5

| January 28, 2011 | 0 Comments

In the fourth installment of my series entitled “Where do pathologists fit into Accountable Care Organizations (ACOs)?, I mentioned that I personally had not come across much information on oncology and ACOs.  In this post, I highlight some information about the potential plans of a large, single-specialty integrated oncology practice. Ben Calhoun MD PhD.  As […]

Continue Reading

Where do Pathologists fit into Accountable Care Organizations? – Part 4

| January 24, 2011 | 0 Comments

The following post was submitted by Dr. Ben Calhoun, a practicing pathologist in Charlotte, NC. This is Ben's fourth submission in a continuing series on trying to answer the question "Where do Pathologists fit into Accountable Care Organizations?" By now, almost everyone knows that the Center for Medicare and Medicaid Services (CMS) is drafting regulations […]

Continue Reading